Concepedia

Hans-Peter Gschwind

HG

Statistics

Publications

10

Citations

540

H-Index

10

Active since

1979

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Hans-Peter Gschwind is an author at Novartis (Switzerland) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

1979–2014

10

Publications

10

METABOLISM AND DISPOSITION OF IMATINIB MESYLATE IN HEALTHY VOLUNTEERS

Hans-Peter Gschwind, Ulrike Pfaar, Felix Waldmeier et al. · Drug Metabolism and Disposition · 2005 · 221 citations

Medicine, Pharmacokinetics, Pharmacology +15

Metabolism and Disposition of Vatalanib (PTK787/ZK-222584) in Cancer Patients

Lorenz Jost, Hans-Peter Gschwind, T. Jalava et al. · Drug Metabolism and Disposition · 2006 · 75 citations

Pharmacy, Oncology, Pharmacology +17

Comparative pharmacokinetics of RAD001 (everolimus) in normal and tumor-bearing rodents

Terence O’Reilly, Paul M.J. McSheehy, R. Kawai et al. · Cancer Chemotherapy and Pharmacology · 2009 · 65 citations

Medicine, Pharmacokinetics, Pharmacology +13

Absorption and Disposition of the Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) in Healthy Volunteers: A Case of Xenobiotic Biotransformation Following Endogenous Metabolic Pathways

Markus Zollinger, Hans-Peter Gschwind, Yi Jin et al. · Drug Metabolism and Disposition · 2010 · 48 citations

Medicine, Pharmacokinetics, Pharmacology +14

An iron stable isotope comparison between human erythrocytes and plasma

Friedhelm von Blanckenburg, Marcus Oelze, Dietmar G. Schmid et al. · Metallomics · 2014 · 29 citations · Full text

Humanities, Biochemistry, Elemental Analysis +6

1–5 of 10